Law360, New York (June 21, 2005, 12:00 AM ET) -- Johnson & Johnson’s closely watched patent infringement lawsuit against rival Boston Scientific Corp. over drug-coated stents has gone to the jury following closing arguments on Monday.
In closing arguments, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson’s groundbreaking invention of stenting technology “revolutionized cardiology.”
Diskant claimed Boston Scientific sought a “free ride” on his client's stent innovations by using the technology without permission since 1995.
“You have to pay for the ideas you take,”Diskant said.
Kirkland & Ellis partner John Desmarais, who...
J&J's Patent Suit Against Boston Scientific Heads To Jury
To view the full article, take a free trial now.
